Categories AlphaGraphs, Earnings, Health Care

Vertex Pharmaceuticals reports 14% growth in Q1 revenue: Infographic

Vertex Pharmaceuticals (NASDAQ: VRTX) reported first-quarter 2021 financial results after the regular market hours on Thursday. The pharmaceutical firm reported Q1 revenue of $1.72 billion, up 14% year-over-year and above the Wall Street projection. Net income of $2.98 per share was also above the target that analysts had anticipated.

VRTX shares were down 0.4% immediately following the announcement. The stock has fallen 7% since the beginning of this year.

Vertex Pharma Q1 2021 earnings

Looking forward to listening to management / analyst comments on the results? Stay tuned here for Vertex Pharmaceuticals Q1 earnings call transcript

Prior performance

Most Popular

NFLX Stock: Should you invest in Netflix ahead of upcoming earnings?

For a large number of people, streaming videos and TV shows are the first preference when they want to keep themselves engaged during the lockdown. Streaming giant Netflix, Inc. (NASDAQ:

Earnings: Citigroup (C) Q4 profit beats estimates; revenue edges up

Citigroup Inc. (NYSE: C) on Friday said its fourth-quarter profit decreased despite modest growth in revenues. However, the numbers topped the market’s projections. Fourth-quarter net profit declined to $3.2 billion

JPM Earnings: All you need to know about JPMorgan Chase’s Q4 2021 earnings results

JPMorgan Chase & Co. (NYSE: JPM) reported fourth-quarter 2021 earnings results today. Reported revenue was flat year-over-year to $29.3 billion. Net income decrease 12% to $12.1 billion while EPS decreased

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top